Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Virtual Congress 2020

Management paradigms for metastatic castration-sensitive prostate cancer

How does the clinician use quality of life data to decide between chemotherapy and hormonal therapy?

Date

16 Oct 2020

Session

Management paradigms for metastatic castration-sensitive prostate cancer

Topics

Cytotoxic Therapy

Tumour Site

Prostate Cancer

Presenters

Alicia Morgans

Authors

A.K. Morgans

Author affiliations

  • Medicine, Northwestern University Feinberg School of Medicine, 60611 - Chicago/US

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Q&A and live discussion

Presenter: Karim Fizazi

Session: Management paradigms for metastatic castration-sensitive prostate cancer

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.